Perspective Therapeutics, Inc. — Director's Dealing 2019

Sep 4, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2018-12-03

Reporting Person: Hunt Jonathan Robert (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$0.4300	2028-12-03	Common Stock (150000)		Direct

Footnotes

F1: 25% vested on 12/3/2018, and the remaining 75% will vest in 25% increments commencing on 12/3/2019 and on each anniversary thereafter, until fully vested.